Hopes rise for mRNA cancer vaccine after Moderna trial shows promise
Pharma company Moderna made a significant announcement this week, revealing that its mRNA cancer vaccine, initially designed for melanoma, shows potential in treating head and neck cancer as well. This development represents a milestone in expanding the application of mRNA technology beyond COVID treatments. Moderna’s revelation caused a surge in its stock price, highlighting […]